Profilo
Sandra Zimmerman served as the Chief Financial & Accounting Officer at Proteostasis Therapeutics, Inc. in 2019.
Precedenti posizioni note di Sandra Zimmerman
Società | Posizione | Fine |
---|---|---|
PROTEOSTASIS THERAPEUTICS, INC. | Direttore Finanziario/CFO | 31/05/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Sandra Zimmerman